NCT05503251
Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases
StatusCompleted
PhasePhase 2
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 6 words
- Trial completed
- Primary completion date changed from estimate of Jun 28, 2026 to Jun 30, 2025
- Notable Primary and study completion dates pushed to Jun 28, 2026v6
- Notable Phase: Not applicable to Phase 2
- Primary completion date: Apr 28, 2025 to Oct 28, 2025
- Study completion date: Aug 30, 2025 to Dec 31, 2025
Minor Trial status: Recruiting to Active, Not Recruitingv4 Show 4 more changesShow less
- Enrollment target: estimated 47 to confirmed 110
- Primary completion date: Dec 31, 2024 to Apr 28, 2025
- Study completion date: Dec 31, 2025 to Aug 30, 2025
- Site details revised
- Notable Phase: Phase 2 to Not applicable
- Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Oct 31, 2022 to Aug 30, 2022
- Site details revised
- Notable Eligibility criteria shortened, about 3 wordsv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Quality of life (QOL)
Timeframe: Up to 12 months after radiation therapy
Arms and interventions
Arm I (neuropsychological evaluation)Experimental
Patients undergo neuropsychological evaluations with a certified neuropsychologist at baseline, 3 months, and 6 months.
Arm II (usual care)Active comparator
Patients receive usual care.
Other: Best Practice, Quality-of-Life Assessment, Questionnaire Administration
Behavioral: Neuropsychological Assessment
Sites
1 site in 1 country
- Ohio State University Comprehensive Cancer CenterColumbus, Ohio, United States